tirzepatide cardiovascular outcomes trial results august 2025 of semaglutide and for patients with type 2 diabetes in clinical practice 60-Second Journal Club: The SUMMIT

Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-arrestin-dependent signaling

However, medical supervision is important for advanced cases

GLP-1 wont cause drinking to gently slope downward, rather, it'll spark waves of volatility, with sharp drops in consumption followed by quick rebounds

By 3 months (after titrating to ~7.5 mg), you might see roughly 810% body weight down in some cases [35] though it varies

[1] This is known as titration and is designed to give your body time to adapt and so the medication is gentler on your digestive system, helping minimise unpleasant side effects like nausea or diarrhoea